Fierce Pharma

Daiichi taps Genesis to handle commercialization of leukemia med Vanflyta in 13 European countries

Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug ...

Ultragenyx vows 'significant' cutbacks as failed study wipes more than $1 billion from Novato biotech's market value

Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google.
IEEE

Study on the Evolution Law of Ablation Characteristic Signals of High-Voltage Cable Buffer Layer Based on Multi-Parameter Analysis

Abstract: In recent years, breakdown failures caused by the ablation of the buffer layer in high-voltage cables have occurred frequently, posing a serious threat to the safe operation of the power ...
Investopedia

Bitcoin Genesis Block Explained: Key Facts, Secrets, and Significance

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Erika Rasure is globally-recognized as a leading ...
Investopedia

Understanding Event Studies: Methods and Uses in Investing

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
BMJ

Medicine authentication technology: a quantitative study of incorrect quarantine, average response times and offline issues in a hospital setting

Objectives To introduce serialised medicines into an operational hospital dispensary and assess the technical effectiveness of digital medicine authentication (MA) technology under European Union ...